Connor Chamberlain Maintained (CDNA) at Strong Buy with Increased Target to $32 on, Aug 1st, 2024
Connor Chamberlain of Craig-Hallum, Maintained "CareDx, Inc" (CDNA) at Strong Buy with Increased Target from $22 to $32 on, Aug 1st, 2024.
Connor has made no other calls on CDNA in the last 4 months.
There are 3 other peers that have a rating on CDNA. Out of the 3 peers that are also analyzing CDNA, 1 agrees with Connor's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andrew Cooper of "Raymond James" Downgraded from Buy to Hold on, Monday, May 13th, 2024
These are the ratings of the 2 analyists that currently disagree with Connor
- Mason Carrico of "Stephens & Co." Maintained at Buy with Increased Target to $18 on, Monday, May 13th, 2024
- Alexander Nowak of "Craig-Hallum" Upgraded from Hold to Strong Buy and Increased Target to $15 on, Wednesday, May 1st, 2024
Contributing Sources